Honeywell International Inc. (NYSE: HON) reported higher earnings for the third quarter of 2019, despite a decline in sales. Adjusted earnings exceeded
Honeywell (HON) Q3 earnings exceed forecast, sales miss; lifts FY19 EPS outlook
Categories
Other Industries
Crown Castle International (NYSE: CCI): Q3 2019 Earnings Snapshot
-- Crown Castle International Corp. (NYSE: CCI) reported third-quarter 2019 earnings of $0.58 per share, vs. $0.49 per share expected. -- Revenues
Alcoa misses Q3 bottom-line by 11 cents, mulls asset sale
Despite analysts slashing third quarter bottom-line estimate on Alcoa Corporation (NYSE: AA) stock five times in the trailing quarter, the aluminum product
Softbank’s hopes are now pinned on this rapid-growth “WeWork-like” unicorn
It’s been a pretty rough year so far for Japanese conglomerate Softbank, which invests primarily in technology firms around the globe. It’s
United States Steel stock takes a hit after weak guidance
Shares of United States Steel Corporation (NYSE: X) were down 11.8% in morning trade on Thursday. The stock took a hit after
FedEx stock falls on Q1 earnings miss and lowered 2020 guidance
Logistics giant FedEx (NYSE: FDX) reported its first quarter 2020 earnings results that missed analysts' views. The company also lowered its guidance
WeWork IPO delay: Causes and impact
WeWork, which got rebranded as The We Company in 2019, has postponed its much-anticipated initial public offering with the completion to occur
FedEx likely to report weak Q1 earnings on Sept 17
FedEx Corporation (NYSE: FDX) is set to report its earnings results for the first quarter of fiscal 2020 on Tuesday, September 17,
Duluth Holdings Q2 profit misses estimates, cuts FY19 forecast
Duluth Holdings (NASDAQ: DLTH), doing business as Duluth Trading Co., reported a 70% dip in earnings for the second quarter due to
Chinese market recovery reflects in Fang Holdings’ Q2 earnings
Fang Holdings Ltd. (NYSE: SFUN), which operates as a real estate internet portal in China, said it swung to a profit of 5
Tiffany Q2 profit drops 6% but beats estimates
Tiffany & Co. (NYSE: TIF) reported a 6% drop in earnings for the second quarter due to weak demand from foreign tourists,
Earnings preview: Tiffany might not shine in Q2
Tiffany & Co. (NYSE: TIF) is scheduled to report second quarter 2019 earnings results on Wednesday, August 28, before the opening bell.
What to expect from Hibbett Sports Q2 earnings
Hibbett Sports (NASDAQ: HIBB) is set to report its earnings results for the second quarter of 2020 on Friday before the market
Toll Brothers surpasses Q3 estimates; orders drop
Homebuilder Toll Brothers' (NYSE: TOL) third quarter 2019 bottom and top-line results exceeded analysts' views. For the July quarter, Toll Brothers reported
La-Z-Boy reports Q1 earnings beat, but sales miss estimates
La-Z-Boy Incorporated (NYSE: LZB) stock surged above 3% after the bell as the first quarter earnings came ahead of estimates. However, the
Medtronic posts upbeat Q1 results, raises EPS outlook
Irish medical technology firm Medtronic plc (NYSE: MDT) on Tuesday announced results for the first quarter of 2020 that were better than what
What to look for when Lowe’s Companies reports Q2 earnings
Lowe's Companies (NYSE: LOW) is scheduled to report its earnings results for the second quarter on Wednesday before the market opens. The
Estée Lauder Q4 profit beats estimates, guides Q1, FY20 above consensus
The Estée Lauder Companies Inc. (NYSE: EL) reported a 16% drop in earnings for the fourth quarter due to higher costs and
Earnings preview: What to look for when Medtronic reports Q1 2020 results
Medtronic plc (NYSE: MDT) is scheduled to report first quarter 2020 earnings results on Tuesday, August 20, before the opening bell. Analysts
Toll Brothers Q3 earnings preview: Weak demand likely to weigh on sales
Toll Brothers (NYSE: TOL) disappointed investors in March when it issued weak guidance while reporting above-consensus results for the second quarter. The
AbbVie wins FDA approval for Rinvoq, stock gains
Shares of biopharmaceutical firm AbbVie (NYSE: ABBV) jumped 2.1% after the company received approval from the US Food and Drug Administration for